SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is experiencing a surge in discussion, fueled by news of a significant initiative to lower mortgage rates, which the community believes will invigorate the housing market. Investors are actively anticipating a potential short squeeze and rapid appreciation, connecting increased housing transaction activity from more accessible mortgage rates directly to Opendoor's business model. This renewed optimism has many longs celebrating a potential return to previous highs.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending amid fresh bullish analyst sentiment, notably Needham naming it a "Top Pick," driven by its strategic value in providing human-generated content for AI training models and lucrative licensing deals. While some express concerns over its valuation, the community remains divided between those anticipating further growth and a squeeze, and others citing price volatility.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is experiencing significant upward momentum after announcing an agreement with Meta Platforms to develop a 1.2 GW nuclear power campus supporting AI data centers, which many view as a major validation for advanced nuclear technology. The community is actively debating the significance of this catalyst, with bulls pointing to strong institutional accumulation and potential short squeezes while skeptics note the company's lack of current revenue and long-term project timelines. This surge underscores the growing market conviction that nuclear energy is crucial for meeting the escalating power demands of the AI industry.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to CEO Ryan Cohen's new performance-based compensation plan, which ties his pay to achieving an ambitious market capitalization target, renewing speculation among retail investors. This news has ignited intense debate within the community, with many 'apes' seeing it as a bullish alignment for a potential 'moonshot' or 'MOASS,' while others remain skeptical, pointing to past unfulfilled hype dates and persistent market manipulation. The conversation is highly charged, centered on whether this strategy can finally unlock the meme stock's short squeeze potential.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as it pushes past the $100 mark, reaching new highs amid strong bullish sentiment. The community is actively discussing recent analyst upgrades that counter a widely dismissed downgrade, while anticipating news on the BlueBird 6 satellite's unfurling and its implications for direct-to-device technology and critical government applications.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing increased attention driven by strong political endorsement for its domestic chip manufacturing and the rollout of its advanced 18A process technology. The community is expressing widespread bullish sentiment, anticipating significant future growth and discussing perceived resistance from bearish positions.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX) is trending upwards following positive FDA feedback, which confirmed a clear path for its lead drug application without requiring additional trials, significantly de-risking the asset. This regulatory clarity has ignited widespread community speculation about a potential buyout, with many highlighting the drug's "best-in-class" potential and the stock's perceived undervaluation, alongside anticipation of a short squeeze.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

Rocket Companies is actively trending following President Trump's announcement regarding significant mortgage bond purchases, which has ignited speculation of falling interest rates. The community is buzzing with expectations of a massive refinancing boom and a potential short squeeze, fueling strong bullish sentiment for the stock. Many believe this macro shift, coupled with Rocket's integrated platform and recent acquisitions, positions the company as a key beneficiary in an anticipated housing market upturn.

UWM Holdings Corp. is a wholesale mortgage lender, which underwrites and provides closing documentation for residential mortgage loans originated by independent mortgage brokers, correspondents, small banks and local credit unions. The firm provides independent mortgage advisors with a set of technologically driven tools and a value proposition that enables them to offer borrowers that meet the credit rating standards compelling financing alternatives. The company was founded in 1986 and is headquartered in Pontiac, MI.

UWM Holdings Corporation - Ordinary Shares - Class A

UWMC is trending as community chatter intensifies around former President Trump's proposal for government mortgage bond purchases, aiming to significantly lower rates and potentially spark a housing market recovery. This news, combined with recent mortgage rate declines and the strategic acquisition of Two Harbors Investment, fuels investor debate over UWMC's long-term potential and its current valuation compared to peers amidst ongoing concerns about CEO stock sales.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is heavily trending amid recent price target adjustments and a fervent debate surrounding its proposed acquisition of Warner Bros. Discovery, with a rival bid adding complexity. While many investors are expressing frustration over persistent downward pressure and perceived manipulation, a bullish counter-narrative highlights the stock as oversold, anticipating a significant rebound driven by strong fundamentals and upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MCRB $15.19 bid 
Holding long position at a loss 
https://stocktwits.com/G101SPM/message/585813939 
note: Seres Therapeutics (MCRB) implemented a 1-for-20 reverse stock split that became effective before the market opened on April 22, 2025.  
DAC (dollar average cost with 1:20 stock split is $28.30) 
EXIT not determined.  
UPDATE: 
1. Flagship Achievement: VOWST™  
Seres developed VOWST, the first-ever FDA-approved oral live biotherapeutic.  
Purpose: It is used to prevent the recurrence of Clostridioides difficile infection (CDI) in adults. 
Divestiture: In September 2024, Seres sold the VOWST business to Nestlé Health Science. This sale allowed Seres to retire debt and refocus its resources on its remaining clinical pipeline.  
2. Primary Clinical Pipeline (2026 Focus) 
Following the VOWST sale, Seres has pivoted to advancing its next generation of &quot;cultivated&quot; (lab-grown) microbial consortia.  
SER-155: The current lead candidate, designed to prevent bacterial bloodstream infections (BSIs) and graft-versus-host disease (GvHD) in patients undergoing stem cell transplants. It has received FDA Breakthrough Therapy and Fast Track designations. 
SER-147: An early-stage program aimed at preventing infections in patients with chronic liver disease. 
Inflammatory Diseases: The company continues research into microbiome-based treatments for Ulcerative Colitis and other immune-related gastrointestinal disorders.  
3. Core Technology: The Ecobiotic® Platform 
Seres uses a proprietary &quot;reverse translation&quot; engine to design its drugs.  
Design: They analyze human clinical data to identify missing beneficial bacteria and then create &quot;consortia&quot; (defined groups) of specific bacterial strains. 
Mechanism: Unlike traditional antibiotics that kill bacteria, Seres&#39; therapies aim to restore health by repopulating the gut with beneficial microbes that outcompete pathogens and strengthen the intestinal lining.  
4. Company Status &amp; Strategy 
Headquarters: Cambridge, Massachusetts. 
Financial Position: After the VOWST sale and recent workforce reductions, the company reported a return to profitability in early 2025 and has projected its cash runway to last into the second quarter of 2026. 
Leadership: The company recently shifted to a co-CEO management structure to explore further strategic deals and partnerships

Alex

MCRB $1.06 ask. BUY/ADD TO LONG LOSITION. DAC (dollar average cost) (7) $1.415. EXIT $4.50 long term.

Stocktwits

Northridge Company (@G101SPM) | Stocktwits

StockTwits Web

Seres Therapeutics Inc

 $15.19 bid 
Holding long position at a loss 


 
note: Seres Therapeutics (MCRB) implemented a 1-for-20 reverse stock split that became effective before the market opened on April 22, 2025.  
DAC (dollar average cost with 1:20 stock split is $28.30) 
EXIT not determined.  
UPDATE: 
1. Flagship Achievement: VOWST™  
Seres developed VOWST, the first-ever FDA-approved oral live biotherapeutic.  
Purpose: It is used to prevent the recurrence of Clostridioides difficile infection (CDI) in adults. 
Divestiture: In September 2024, Seres sold the VOWST business to Nestlé Health Science. This sale allowed Seres to retire debt and refocus its resources on its remaining clinical pipeline.  
2. Primary Clinical Pipeline (2026 Focus) 
Following the VOWST sale, Seres has pivoted to advancing its next generation of "cultivated" (lab-grown) microbial consortia.  
SER-155: The current lead candidate, designed to prevent bacterial bloodstream infections (BSIs) and graft-versus-host disease (GvHD) in patients undergoing stem cell transplants. It has received FDA Breakthrough Therapy and Fast Track designations. 
SER-147: An early-stage program aimed at preventing infections in patients with chronic liver disease. 
Inflammatory Diseases: The company continues research into microbiome-based treatments for Ulcerative Colitis and other immune-related gastrointestinal disorders.  
3. Core Technology: The Ecobiotic® Platform 
Seres uses a proprietary "reverse translation" engine to design its drugs.  
Design: They analyze human clinical data to identify missing beneficial bacteria and then create "consortia" (defined groups) of specific bacterial strains. 
Mechanism: Unlike traditional antibiotics that kill bacteria, Seres' therapies aim to restore health by repopulating the gut with beneficial microbes that outcompete pathogens and strengthen the intestinal lining.  
4. Company Status & Strategy 
Headquarters: Cambridge, Massachusetts. 
Financial Position: After the VOWST sale and recent workforce reductions, the company reported a return to profitability in early 2025 and has projected its cash runway to last into the second quarter of 2026. 
Leadership: The company recently shifted to a co-CEO management structure to explore further strategic deals and partnerships